Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 134
Filtrar
1.
J Lipid Res ; 65(4): 100529, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38467328

RESUMEN

FASN, the sole cytosolic enzyme responsible for de novo palmitate synthesis in mammalian cells, has been associated with poor prognosis in cancer and shown to cause drug and radiation resistance by upregulating DNA damage repair via suppression of p65 expression. Targeting FASN by repurposing proton pump inhibitors has generated impressive outcomes in triple-negative breast cancer patients. While p65 regulation of DNA damage repair was thought to be due to its suppression of poly(ADP-ribose) polymerase 1 gene transcription, the mechanism of FASN regulation of p65 expression was unknown. In this study, we show that FASN regulates p65 stability by controlling its phosphorylation at Thr254, which recruits the peptidyl-prolyl cis/trans isomerase Pin1 that is known to stabilize many proteins in the nucleus. This regulation is mediated by palmitate, the FASN catalytic product, not by FASN protein per se. This finding of FASN regulation of p65 stability via phosphorylation of Thr254 and isomerization by Pin1 implicates that FASN and its catalytic product palmitate may play an important role in regulating protein stability in general and p65 more specifically.


Asunto(s)
Acido Graso Sintasa Tipo I , Peptidilprolil Isomerasa de Interacción con NIMA , Peptidilprolil Isomerasa de Interacción con NIMA/metabolismo , Peptidilprolil Isomerasa de Interacción con NIMA/genética , Humanos , Fosforilación , Estabilidad Proteica , Factor de Transcripción ReIA/metabolismo , Isomerismo
2.
J Biol Chem ; 299(5): 104658, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-36997088

RESUMEN

Eukaryotic initiation factor 3d (eIF3d), a known RNA-binding subunit of the eIF3 complex, is a 66 to 68-kDa protein with an RNA-binding motif and a cap-binding domain. Compared with other eIF3 subunits, eIF3d is relatively understudied. However, recent progress in studying eIF3d has revealed a number of intriguing findings on its role in maintaining eIF3 complex integrity, global protein synthesis, and in biological and pathological processes. It has also been reported that eIF3d has noncanonical functions in regulating translation of a subset of mRNAs by binding to 5'-UTRs or interacting with other proteins independent of the eIF3 complex and additional functions in regulating protein stability. The noncanonical regulation of mRNA translation or protein stability may contribute to the role of eIF3d in biological processes such as metabolic stress adaptation and in disease onset and progression including severe acute respiratory syndrome coronavirus 2 infection, tumorigenesis, and acquired immune deficiency syndrome. In this review, we critically evaluate the recent studies on these aspects of eIF3d and assess prospects in understanding the function of eIF3d in regulating protein synthesis and in biological and pathological processes.


Asunto(s)
Progresión de la Enfermedad , Factor 3 de Iniciación Eucariótica , Biosíntesis de Proteínas , Caperuzas de ARN , Humanos , COVID-19 , Factor 3 de Iniciación Eucariótica/metabolismo , Caperuzas de ARN/metabolismo , Síndrome de Inmunodeficiencia Adquirida , Carcinogénesis , Regiones no Traducidas 5'/genética
3.
J Biol Chem ; 298(7): 102044, 2022 07.
Artículo en Inglés | MEDLINE | ID: mdl-35595099

RESUMEN

Eukaryotic translation initiation factor 3 subunit A (eIF3a), the largest subunit of the eIF3 complex, has been shown to be overexpressed in malignant cancer cells, potentially making it a proto-oncogene. eIF3a overexpression can drive cancer cell proliferation but contributes to better prognosis. While its contribution to prognosis was previously shown to be due to its function in suppressing synthesis of DNA damage repair proteins, it remains unclear how eIF3a regulates cancer cell proliferation. In this study, we show using genetic approaches that eIF3a controls cell proliferation by regulating glucose metabolism via the phosphorylation and activation of AMP-activated protein kinase alpha (AMPKα) at Thr172 in its kinase activation loop. We demonstrate that eIF3a regulates AMPK activation mainly by controlling synthesis of the small GTPase Rheb, largely independent of the well-known AMPK upstream liver kinase B1 and Ca2+/calmodulin-dependent protein kinase kinase 2, and also independent of mammalian target of rapamycin signaling and glucose levels. Our findings suggest that glucose metabolism in and proliferation of cancer cells may be translationally regulated via a novel eIF3a-Rheb-AMPK signaling axis.


Asunto(s)
Proteínas Quinasas Activadas por AMP , Factor 3 de Iniciación Eucariótica , Glucosa , Proteína Homóloga de Ras Enriquecida en el Cerebro , Proteínas Quinasas Activadas por AMP/genética , Proteínas Quinasas Activadas por AMP/metabolismo , Línea Celular Tumoral , Proliferación Celular , Factor 3 de Iniciación Eucariótica/genética , Factor 3 de Iniciación Eucariótica/metabolismo , Glucosa/metabolismo , Humanos , Proteína Homóloga de Ras Enriquecida en el Cerebro/genética , Proteína Homóloga de Ras Enriquecida en el Cerebro/metabolismo
4.
Int J Mol Sci ; 24(8)2023 Apr 21.
Artículo en Inglés | MEDLINE | ID: mdl-37108784

RESUMEN

Chemoresistance is a major health concern affecting cancer patients. Resistance is multifactorial, with one mechanism being the increased expression of ABC transporters (such as MDR1 and MRP1), which are drug efflux transporters capable of preventing intracellular accumulation of drugs and cell death. Our lab showed that the loss of Adenomatous Polyposis Coli (APC) caused an intrinsic resistance to doxorubicin (DOX), potentially through an enhanced tumor-initiating cell (TIC) population and the increased activation of STAT3 mediating the expression of MDR1 in the absence of WNT being activated. Here, in primary mouse mammary tumor cells, the loss of APC decreased the accumulation of DOX while increasing the protein levels of MDR1 and MRP1. We demonstrated decreased APC mRNA and protein levels in breast cancer patients compared with normal tissue. Using patient samples and a panel of human breast cancer cell lines, we found no significant trend between APC and either MDR1 or MRP1. Since the protein expression patterns did not show a correlation between the ABC transporters and the expression of APC, we evaluated the drug transporter activity. In mouse mammary tumor cells, the pharmacological inhibition or genetic silencing of MDR1 or MRP1, respectively, decreased the TIC population and increased DOX-induced apoptosis, supporting the use of ABC transporter inhibitors as therapeutic targets in APC-deficient tumors.


Asunto(s)
Poliposis Adenomatosa del Colon , Neoplasias de la Mama , Humanos , Ratones , Animales , Femenino , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Resistencia a Antineoplásicos/genética , Doxorrubicina/farmacología , Doxorrubicina/uso terapéutico , Transportadoras de Casetes de Unión a ATP/genética , Transportadoras de Casetes de Unión a ATP/metabolismo , Muerte Celular , Línea Celular Tumoral , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/genética , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/metabolismo
5.
Entropy (Basel) ; 25(6)2023 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-37372269

RESUMEN

Measuring the correlation between belief functions is an important issue in Dempster-Shafer theory. From the perspective of uncertainty, analyzing the correlation may provide a more comprehensive reference for uncertain information processing. However, existing studies about correlation have not combined it with uncertainty. In order to address the problem, this paper proposes a new correlation measure based on belief entropy and relative entropy, named a belief correlation measure. This measure takes into account the influence of information uncertainty on their relevance, which can provide a more comprehensive measure for quantifying the correlation between belief functions. Meanwhile, the belief correlation measure has the mathematical properties of probabilistic consistency, non-negativity, non-degeneracy, boundedness, orthogonality, and symmetry. Furthermore, based on the belief correlation measure, an information fusion method is proposed. It introduces the objective weight and subjective weight to assess the credibility and usability of belief functions, thus providing a more comprehensive measurement for each piece of evidence. Numerical examples and application cases in multi-source data fusion demonstrate that the proposed method is effective.

6.
Bioorg Med Chem ; 65: 116761, 2022 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-35504208

RESUMEN

Survivin, a member of the inhibitor of apoptosis protein family, exists as a homodimer and is aberrantly upregulated in a wide spectrum of cancers. It was thought to be an ideal target due to its lack of expression in most adult normal tissues and importance in cancer cell survival. However, it has been challenging to target survivin due to its "undruggable" nature. We previously attempted to target its dimerization domain with a hypothesis that inhibiting survivin dimerization would promote its degradation in proteasome, which led to identification of a lead small-molecule inhibitor, LQZ-7F. LQZ-7F consists of a flat tetracyclic aromatic core with labile hydrazone linking a 1,2,5-oxadiazole moiety. In this study, we tested the hypothesis that LQZ-7F could be developed as a prodrug because the labile hydrazone linker could be hydrolyzed, releasing the tetracyclic aromatic core. To this end, we synthesized the tetracyclic aromatic core (LQZ-7F1) using reported procedure and tested LQZ-7F1 for its biological activities. Here we show that LQZ-7F1 has a significantly improved potency with submicromolar IC50's and induces spontaneous apoptosis in prostate cancer cells. It also more effectively inhibits survivin dimerization and induces survivin degradation in a proteasome-dependent manner than LQZ-7F. We also show that the combination of LQZ-7F1 and docetaxel have strong synergism in inhibiting prostate cancer cell survival. Together, we conclude that the hydrazone linker with the oxadiazole tail is dispensable for survivin inhibition and the survivin dimerization inhibitor, LQZ-7F, may be developed as a prodrug for prostate cancer treatment and to overcome docetaxel resistance.


Asunto(s)
Profármacos , Neoplasias de la Próstata , Apoptosis , Línea Celular Tumoral , Dimerización , Docetaxel/farmacología , Docetaxel/uso terapéutico , Humanos , Hidrazonas/farmacología , Hidrazonas/uso terapéutico , Proteínas Inhibidoras de la Apoptosis/metabolismo , Masculino , Proteínas Asociadas a Microtúbulos/metabolismo , Oxadiazoles/farmacología , Oxadiazoles/uso terapéutico , Profármacos/farmacología , Neoplasias de la Próstata/tratamiento farmacológico , Neoplasias de la Próstata/metabolismo , Complejo de la Endopetidasa Proteasomal/metabolismo , Survivin/metabolismo
7.
Acta Biochim Biophys Sin (Shanghai) ; 54(5): 647-656, 2022 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-35593465

RESUMEN

Ginsenoside Rh2 is one of rare panaxidiols extracted from Panax ginseng and a potential estrogen receptor ligand that exhibits moderate estrogenic activity. However, the effect of Rh2 on growth inhibition and its underlying molecular mechanism in human breast cells are not fully understood. In this study, we tested cell viability by MTT and colony formation assays. Cell growth and cell cycle were determined to investigate the effect of ginsenoside Rh2 by flow cytometry. The expressions of estrogen receptors (ERs), TNFα, and apoptosis-related proteins were detected by qPCR and western blot analysis. The mechanisms of ERα and ERß action were determined using transfection and inhibitors. Antitumor effect of ginsenoside Rh2 against MCF-7 cells was investigated in xenograft mice. Our results showed that ginsenoside Rh2 induced apoptosis and G1/S phase arrest in MCF-7 cells. Treatment of cells with ginsenoside Rh2 down-regulated protein levels of ERα, and up-regulated mRNA and protein levels of ERß and TNFα. We also found that ginsenoside Rh2-induced TNFα over-expression is through up-regulation of ERß initiated by ginsenoside Rh2. Furthermore, ginsenoside Rh2 induced MCF-7 cell apoptosis via estrogen receptor ß-TNFα pathway in vivo. These results demonstrate that ginsenoside Rh2 promotes TNFα-induced apoptosis and G1/S phase arrest via regulation of ERß.


Asunto(s)
Neoplasias de la Mama , Ginsenósidos , Animales , Femenino , Humanos , Ratones , Apoptosis , Proteínas Reguladoras de la Apoptosis , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/genética , Proliferación Celular , Receptor alfa de Estrógeno , Receptor beta de Estrógeno/genética , Ginsenósidos/farmacología , Ligandos , Receptores de Estrógenos , ARN Mensajero , Factor de Necrosis Tumoral alfa/genética
8.
Biomacromolecules ; 22(2): 540-545, 2021 02 08.
Artículo en Inglés | MEDLINE | ID: mdl-33320659

RESUMEN

Herein, an efficient strategy to fabricate well-organized one-dimensional (1D) inorganic nanostructures is demonstrated by utilizing the hollow tobacco mosaic virus coat protein (TMVCP) as a restrictive template. Considering the advantages of the unique hollow structure and the dynamic self-assembly attribute of TMVCP, foreign nano-objects are successfully encapsulated and conveniently assembled into highly organized 1D chainlike structures in the cavity of the TMVCP multimer (TMV disk). Different kinds of functional nanoparticles, such as gold nanoparticles (AuNPs) and silver sulfide quantum dots (Ag2S QDs), are used to demonstrate the successful construction of ordered 1D nanochains in high yields. Notably, binary nanochains of such different kinds of nanoparticles are also constructed through co-assembling the TMV disk-coated AuNPs and Ag2S QDs. Further, the TMV-assisted AuNP nanochains are grown into the 1D nanowires through in situ Au deposition owing to the spatial confinement of the TMVCP cavity. Together, our findings indicate that the TMV-assisted self-assembly approach, resulting in higher yields and better controllability over the other reported studies based on directly mineralizing the metal architectures in the TMV nanorods, provides enormous potential toward the fabrication of highly complex hybrid-metal nanostructures.


Asunto(s)
Nanopartículas del Metal , Nanoestructuras , Nanotubos , Virus del Mosaico del Tabaco , Oro
9.
Biochem J ; 477(10): 1939-1950, 2020 05 29.
Artículo en Inglés | MEDLINE | ID: mdl-32391557

RESUMEN

eIF3a is a putative subunit of the eukaryotic translation initiation factor 3 complex. Accumulating evidence suggests that eIF3a may have a translational regulatory function by suppressing translation of a subset of mRNAs while accelerating that of other mRNAs. Albeit the suppression of mRNA translation may derive from eIF3a binding to the 5'-UTRs of target mRNAs, how eIF3a may accelerate mRNA translation remains unknown. In this study, we show that eIF3a up-regulates translation of Chk1 but not Chk2 mRNA by interacting with HuR, which binds directly to the 3'-UTR of Chk1 mRNA. The interaction between eIF3a and HuR occurs at the 10-amino-acid repeat domain of eIF3a and the RNA recognition motif domain of HuR. This interaction may effectively circularize Chk1 mRNA to form an end-to-end complex that has recently been suggested to accelerate mRNA translation. Together with previous findings, we conclude that eIF3a may regulate mRNA translation by directly binding to the 5'-UTR to suppress or by interacting with RNA-binding proteins at 3'-UTRs to accelerate mRNA translation.


Asunto(s)
Quinasa 1 Reguladora del Ciclo Celular (Checkpoint 1)/biosíntesis , Proteína 1 Similar a ELAV , Factor 3 de Iniciación Eucariótica , Biosíntesis de Proteínas/fisiología , Línea Celular , Proteína 1 Similar a ELAV/química , Proteína 1 Similar a ELAV/metabolismo , Factor 3 de Iniciación Eucariótica/química , Factor 3 de Iniciación Eucariótica/metabolismo , Regulación de la Expresión Génica , Humanos , Dominios y Motivos de Interacción de Proteínas , Procesamiento Proteico-Postraduccional , ARN Mensajero/química , ARN Mensajero/metabolismo , Proteínas de Unión al ARN
10.
Nano Lett ; 20(2): 1154-1160, 2020 02 12.
Artículo en Inglés | MEDLINE | ID: mdl-31874042

RESUMEN

The science of protein self-assembly has experienced significant development, from discrete building blocks of self-assembled nanoarchitectures to advanced nanostructures with adaptive functionalities. Despite the prominent achievements in the field, the desire of designing de novo protein-nanoparticle (NP) complexes and constructing dynamic NP systems remains highly challenging. In previous works, l-rhamnulose-1-phosphate aldolase (C98RhuA) tetramers were self-assembled into two-dimensional (2D) lattices via disulfide bond interactions. These interactions provided 2D lattices with high structural quality and a sophisticated assembly mode. In this study, we devised a rational design for RhuA building blocks to fabricate 2D functionalized protein lattices. More importantly, the lattices were used to direct the precise assembly of NPs into highly ordered and diverse nanoarchitectures. These structures can be employed as an excellent tool to adequately verify the self-assembly mode and structural quality of the designed RhuA crystals. The subsequent redesign of RhuA building blocks enabled us to predictably produce a novel protein lattice whose conformational dynamics can be controllably regulated. Thus, a dynamic system of AuNP lattices was achieved. Transmission electron microscopy and small-angle X-ray scattering indicated the presence of these diverse NP lattices. This contribution enables the fabrication of future NP structures in a more programmable manner with more expected properties for potential applications in nanoelectronics and other fields.


Asunto(s)
Aldehído-Liasas/química , Complejos Multiproteicos/química , Nanopartículas/química , Nanoestructuras/química , Aldehído-Liasas/ultraestructura , Cristalografía por Rayos X , Complejos Multiproteicos/ultraestructura
11.
J Biol Chem ; 294(52): 20222-20232, 2019 12 27.
Artículo en Inglés | MEDLINE | ID: mdl-31719146

RESUMEN

ATP-binding cassette (ABC) subfamily G member 2 (ABCG2) belongs to the ABC transporter superfamily and has been implicated in multidrug resistance of cancers. Although the structure and function of ABCG2 have been extensively studied, little is known about its biogenesis and the regulation thereof. In this study, using mutagenesis and several biochemical analyses, we show that the positive charges in the vicinity of the RKR motif downstream of the ABC signature drive trafficking of nascent ABCG2 out of the endoplasmic reticulum (ER) onto plasma membranes. Substitutions of and naturally occurring single-nucleotide polymorphisms within these positively charged residues disabled the trafficking of ABCG2 out of the ER. A representative ABCG2 variant in which the RKR motif had been altered underwent increased ER stress-associated degradation. We also found that unlike WT ABCG2, genetic ABCG2 RKR variants have disrupted normal maturation and do not reduce accumulation of the anticancer drug mitoxantrone and no longer confer resistance to the drug. We conclude that the positive charges downstream of the ABC signature motif critically regulate ABCG2 trafficking and maturation. We propose that single-nucleotide polymorphisms of these residues reduce ABCG2 expression via ER stress-associated degradation pathway and may contribute to reduced cancer drug resistance, improving the success of cancer chemotherapy.


Asunto(s)
Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 2/metabolismo , Antineoplásicos/farmacología , Resistencia a Antineoplásicos/efectos de los fármacos , Retículo Endoplásmico/metabolismo , Proteínas de Neoplasias/metabolismo , Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 2/química , Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 2/genética , Adenosina Trifosfato/química , Adenosina Trifosfato/metabolismo , Secuencias de Aminoácidos , Animales , Antineoplásicos/metabolismo , Cicloheximida/farmacología , Dimerización , Resistencia a Antineoplásicos/genética , Estrés del Retículo Endoplásmico/efectos de los fármacos , Glicosilación , Células HEK293 , Semivida , Humanos , Mitoxantrona/metabolismo , Mitoxantrona/farmacología , Mutagénesis Sitio-Dirigida , Proteínas de Neoplasias/química , Proteínas de Neoplasias/genética , Polimorfismo de Nucleótido Simple , Proteolisis/efectos de los fármacos
12.
Small ; 15(10): e1805543, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30706634

RESUMEN

Herein, the assembly of 3D uniform gear-like architectures is demonstrated with a tobacco mosaic virus (TMV) disk as a building block. In this context, the intrinsic behavior of the TMV disk that promotes its assembly into nanotubes is altered by a synergistic effect of dual functional modifications at the 53rd arginine mutation and the introduction of lysine groups in the periphery at 1st and 158th positions of the TMV disk, which results in the formation of 3D gear-like superstructures. Therein, the 53rd arginine moiety significantly strengthens the linkage between TMV disks in the alkaline environment through hydrogen bond interactions. The charge of lysine-modified lateral surfaces is partially neutralized in the alkaline solution, which induces the TMV disk to form a gear-like architecture to maintain its structural stability by exploiting the electrostatic repulsion between neighboring TMV disks. This study not only provides explicit evidence regarding the molecular-level understanding of how the modification of site-specific amino acid affects the assembly of resultant superstructures but also encourages the fabrication of functional protein-based nanoarchitectures.


Asunto(s)
Aminoácidos/química , Virus del Mosaico del Tabaco/química , Proteínas Virales/química , Proteínas de la Cápside/química , Microscopía Electrónica de Transmisión , Nanotubos/química , Nanotubos/ultraestructura
13.
J Pharmacol Exp Ther ; 371(2): 320-326, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31455631

RESUMEN

CC-115, a triazole-containing compound, is a dual mammalian target of rapamycin (mTOR)/DNA-dependent protein kinase (DNA-PK) inhibitor currently in clinical trials. To develop this compound further, we investigated factors that may affect cellular response to CC-115. Previously, fatty acid synthase (FASN) was shown to upregulate DNA-PK activity and contribute to drug resistance; therefore, we hypothesized that FASN may affect cellular response to CC-115. Instead, however, we showed that CC-115 is a substrate of ATP-binding cassette G2 (ABCG2), a member of the ATP-binding cassette transporter superfamily, and that expression of ABCG2, not FASN, affects the potency of CC-115. ABCG2 overexpression significantly increases resistance to CC-115. Inhibiting ABCG2 function, using small-molecule inhibitors, sensitizes cancer cells to CC-115. We also found that CC-115 may be a substrate of ABCB1, another known ABC protein that contributes to drug resistance. These findings suggest that expression of ABC transporters, including ABCB1 and ABCG2, may affect the outcome in clinical trials testing CC-115. Additionally, the data indicate that ABC transporters may be used as markers for future precision use of CC-115. SIGNIFICANCE STATEMENT: In this article, we report our findings on the potential mechanism of resistance to CC-115, a dual inhibitor of mTOR and DNA-PK currently in clinical trials. We show that CC-115 is a substrate of ABCG2 and can be recognized by ABCB1, which contributes to CC-115 resistance. These findings provide novel information and potential guidance on future clinical testing of CC-115.


Asunto(s)
Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 2/metabolismo , Resistencia a Medicamentos/efectos de los fármacos , Proteínas de Neoplasias/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , Pirazinas/farmacología , Serina-Treonina Quinasas TOR/antagonistas & inhibidores , Serina-Treonina Quinasas TOR/metabolismo , Triazoles/farmacología , Subfamilia B de Transportador de Casetes de Unión a ATP/metabolismo , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Ensayos Clínicos como Asunto/métodos , ADN/antagonistas & inhibidores , ADN/metabolismo , Relación Dosis-Respuesta a Droga , Resistencia a Medicamentos/fisiología , Células HEK293 , Humanos , Células MCF-7 , Factores de Riesgo , Especificidad por Sustrato/efectos de los fármacos , Especificidad por Sustrato/fisiología
14.
Proc Natl Acad Sci U S A ; 113(45): E6965-E6973, 2016 Nov 08.
Artículo en Inglés | MEDLINE | ID: mdl-27791122

RESUMEN

Fatty acid synthase (FASN), the sole cytosolic mammalian enzyme for de novo lipid synthesis, is crucial for cancer cell survival and associates with poor prognosis. FASN overexpression has been found to cause resistance to genotoxic insults. Here we tested the hypothesis that FASN regulates DNA repair to facilitate survival against genotoxic insults and found that FASN suppresses NF-κB but increases specificity protein 1 (SP1) expression. NF-κB and SP1 bind to a composite element in the poly(ADP-ribose) polymerase 1 (PARP-1) promoter in a mutually exclusive manner and regulate PARP-1 expression. Up-regulation of PARP-1 by FASN in turn increases Ku protein recruitment and DNA repair. Furthermore, lipid deprivation suppresses SP1 expression, which is able to be rescued by palmitate supplementation. However, lipid deprivation or palmitate supplementation has no effect on NF-κB expression. Thus, FASN may regulate NF-κB and SP1 expression using different mechanisms. Altogether, we conclude that FASN regulates cellular response against genotoxic insults by up-regulating PARP-1 and DNA repair via NF-κB and SP1.

15.
Nano Lett ; 18(10): 6563-6569, 2018 10 10.
Artículo en Inglés | MEDLINE | ID: mdl-30182720

RESUMEN

Highly permeable and precisely size-selective membranes are the subject of continuous pursuit for energy-efficient separation of fine chemicals. However, challenges remain in the fabrication of an ultrathin selective layer with homogeneous pores, in particular, with the pore sizes in the 1-10 nm range. We report the design of a free-standing porous nanosheet assembled with a single layer of proteins. Tobacco mosaic virus mutant (TMVm), a cylinder-shaped protein containing an inner pore of 4 nm in diameter, was cross-linked via a Cu2+-catalyzed disulfide-bond-forming reaction along the 2D orientation. By such a design, ultralarge single-layer TMVm nanosheets extending over tens of micrometers in width and with well-defined nanopores were successfully developed. A ∼40 nm thick ultrafiltration membrane laminated by the single-layer TMVm nanosheets through simple vacuum filtration accomplished the precise separation of ∼4 nm sized substances. Meanwhile, the membrane exhibited water permeance up to ∼7000 L m-2 h-1 bar-1, which is an order of magnitude improvement compared with traditional ultrafiltration membranes with a similar rejection profile.

17.
Mar Drugs ; 15(1)2017 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-28106760

RESUMEN

Ieodomycin B, which shows in vitro antimicrobial activity, was isolated from a marine Bacillus species. A novel asymmetric total synthetic approach to ieodomycin B using commercially available geraniol was achieved. The approach involves the generation of 1,3-trans-dihydroxyl at C-3 and C-5 positions via a Crimmins-modified Evans aldol reaction and a chelation-controlled Mukaiyama aldol reaction of a p-methoxybenzyl-protected aldehyde, as well as the generation of a lactone ring in a deprotection-lactonization one-pot reaction.


Asunto(s)
Lactonas/química , Pironas/química , Antiinfecciosos/química , Organismos Acuáticos/química , Bacillus/química , Estructura Molecular , Estereoisomerismo
18.
Small ; 12(36): 4955-4959, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27061916

RESUMEN

Understanding the self-assembly mechanism of protein building blocks is important to realize the control of protein structures and functionalities. Here, for the first time, four different self-assembly behaviors of tobacco mosaic virus coat protein are reported from 2D disk arrays, disk stacks to 3D tube stacks, and tube bundles, respectively, with rationally mutated cysteines at 1, 3, and 103 sites.


Asunto(s)
Recombinación Genética , Virus del Mosaico del Tabaco/metabolismo , Proteínas Virales/metabolismo , Mutagénesis Sitio-Dirigida , Fosfinas/farmacología , Recombinación Genética/genética , Virus del Mosaico del Tabaco/efectos de los fármacos , Virus del Mosaico del Tabaco/ultraestructura
19.
Small ; 11(21): 2505-9, 2015 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-25612918

RESUMEN

Site-selective biomineralization of Au nanostructures in the interior channel of Tobacco Mosaic Virus (TMV) is achieved by mutating threonine 103 in TMV to cysteine (T103C-TMV) to introduce the strong coordination interaction between the arrayed sulfhydryl ligands and gold species. By finely tuning the reaction conditions, Au nanoparticle chains and Au nanorods are successfully and exclusively synthesized inside the T103C-TMV nanotubes.


Asunto(s)
Oro/química , Nanopartículas del Metal/química , Virus del Mosaico del Tabaco/química , Sustitución de Aminoácidos , Proteínas de la Cápside/química , Proteínas de la Cápside/genética , Proteínas de la Cápside/ultraestructura , Cisteína/química , Nanopartículas del Metal/ultraestructura , Nanopartículas del Metal/virología , Microscopía Electrónica de Transmisión , Mutagénesis Sitio-Dirigida , Nanotubos/química , Nanotubos/ultraestructura , Nanotubos/virología , Multimerización de Proteína , Virus del Mosaico del Tabaco/genética , Virus del Mosaico del Tabaco/ultraestructura
20.
Mol Pharmacol ; 86(5): 561-9, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25189999

RESUMEN

Although gemcitabine is the most commonly used drug for treating pancreatic cancers, acquired gemcitabine resistance in a substantial number of patients appears to hinder its effectiveness in successful treatment of this dreadful disease. To understand acquired gemcitabine resistance, we generated a gemcitabine-resistant pancreatic cancer cell line using stepwise selection and found that, in addition to the known mechanisms of upregulated expression of ribonucleotide reductase, 14-3-3σ expression is dramatically upregulated, and that 14-3-3σ overexpression contributes to the acquired resistance to gemcitabine and cross-resistance to cytarabine. We also found that the increased 14-3-3σ expression in the gemcitabine-resistant cells is due to demethylation of the 14-3-3σ gene during gemcitabine selection, which could be partially reversed with removal of the gemcitabine selection pressure. Most importantly, the reversible methylation/demethylation of the 14-3-3σ gene appears to be carried out by DNA methyltransferase 1 under regulation by Uhrf1. These findings suggest that the epigenetic regulation of gene expression may play an important role in gemcitabine resistance, and that epigenetic modification is reversible in response to gemcitabine treatment.


Asunto(s)
Proteínas 14-3-3/genética , Proteínas Potenciadoras de Unión a CCAAT/genética , ADN (Citosina-5-)-Metiltransferasas/genética , ADN/genética , Desoxicitidina/análogos & derivados , Resistencia a Antineoplásicos/genética , Epigénesis Genética/genética , Línea Celular Tumoral , Citarabina/farmacología , ADN (Citosina-5-)-Metiltransferasa 1 , Desoxicitidina/farmacología , Resistencia a Antineoplásicos/efectos de los fármacos , Epigénesis Genética/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/genética , Humanos , Células MCF-7 , Neoplasias Pancreáticas/genética , Ribonucleótido Reductasas/genética , Ubiquitina-Proteína Ligasas , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/genética , Gemcitabina
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda